DHRHealthcare● Live Quotes Active

Danaher Corporation

Held by 1 top hedge funds (3.0% of tracked funds)

Live Price
24h Change
Mega Funds Holding
1/ 33 funds

Coverage: 3.0%

Avg Portfolio Weight
4%

Top: Glenview Capital Management (4%)

Wall St Sentiment
0%Bullish
+0/1/-0
Total Tracked Shares
1.1Mshares

Based on SEC 13F filings

SGDC Dual-Core EngineSuper-Growth Dual-Core Radar

🚀DHR SGDC Quant Rating & Setup

Open SGDC Screener↗
4P Grade
B 级(70分)
RS Rating
57/ 99
Pattern Setup
Watchlist
Pivot Benchmark
$227.98Support: $210.88

📌 Business Moat Summary:Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

📈8-Quarter Institutional Ownership Evolution

Historical trajectory of institutional holders and allocation weight across the last 8 quarters

Select Quarter:
4% 均仓
1 f2026 Q2
3.6% 均仓
1 f2026 Q1
4% 均仓
1 f2025 Q4
5.3% 均仓
1 f2025 Q3
1.9% 均仓
1 f2025 Q2
3.6% 均仓
1 f2025 Q1
6.1% 均仓
1 f2024 Q4
0.8% 均仓
1 f2024 Q3
2026 Q2|Report Date: 2026-06-30
Holding Funds: 1 家Total Shares: 1.1MAvg Weight: 4%

🏛️Institutional Investors Holding this Stock

Examine each hedge fund holding this ticker, weight, shares, and recent action

Sort by:
Manager / FundFund AUMWeightShares HeldActionAction
Manager:Larry Robbins
$5.5B
4.0%
1.1MHOLDView Full 13F →
🎯

Want to see Wall Street's Top 50 Consensus Buys?

Instead of checking individual stocks, get the complete list of high-conviction overlap picks across 33 hedge funds.

Go to Consensus Screener →

⚡Planning to trade DHR?

Add this symbol to your private journal or dividend tracker to monitor institutional moves.

Who Owns DHR? Top Hedge Funds Holding Danaher Corporation & 13F Analysis 2026 | WhaleTracker